Personalis, Inc. (PSNL)

USD 3.21

(-2.58%)

Total Liabilities Summary of Personalis, Inc.

  • Personalis, Inc.'s latest annual total liabilities in 2023 was 95.65 Million USD , up 28.29% from previous year.
  • Personalis, Inc.'s latest quarterly total liabilities in 2024 Q1 was 74.58 Million USD , down -22.03% from previous quarter.
  • Personalis, Inc. reported annual total liabilities of 74.56 Million USD in 2022, down -13.53% from previous year.
  • Personalis, Inc. reported annual total liabilities of 86.22 Million USD in 2021, up 72.81% from previous year.
  • Personalis, Inc. reported quarterly total liabilities of 74.58 Million USD for 2024 Q1, down -22.03% from previous quarter.
  • Personalis, Inc. reported quarterly total liabilities of 78.54 Million USD for 2023 Q1, up 5.35% from previous quarter.

Annual Total Liabilities Chart of Personalis, Inc. (2023 - 2017)

Historical Annual Total Liabilities of Personalis, Inc. (2023 - 2017)

Year Total Liabilities Total Liabilities Growth
2023 95.65 Million USD 28.29%
2022 74.56 Million USD -13.53%
2021 86.22 Million USD 72.81%
2020 49.89 Million USD -1.39%
2019 50.6 Million USD -65.82%
2018 148.05 Million USD 17.35%
2017 126.16 Million USD 0.0%

Peer Total Liabilities Comparison of Personalis, Inc.

Name Total Liabilities Total Liabilities Difference
Aclaris Therapeutics, Inc. 40.22 Million USD -137.801%
Applied DNA Sciences, Inc. 8.77 Million USD -989.602%
Aspira Women's Health Inc. 8.62 Million USD -1008.821%
Biodesix, Inc. 94.51 Million USD -1.208%
BioNexus Gene Lab Corp. 1.74 Million USD -5391.46%
bioAffinity Technologies, Inc. 3.36 Million USD -2741.639%
bioAffinity Technologies, Inc. 3.36 Million USD -2741.639%
Bionano Genomics, Inc. 118.24 Million USD 19.103%
CareDx, Inc 223.28 Million USD 57.159%
Check-Cap Ltd. 1.33 Million USD -7092.331%
Castle Biosciences, Inc. 86.54 Million USD -10.534%
DarioHealth Corp. 38.24 Million USD -150.119%
Exact Sciences Corporation 3.32 Billion USD 97.124%
Fulgent Genetics, Inc. 139.82 Million USD 31.586%
Guardant Health, Inc. 1.62 Billion USD 94.123%
ICON Public Limited Company 7.74 Billion USD 98.766%
IDEXX Laboratories, Inc. 1.77 Billion USD 94.612%
Illumina, Inc. 4.36 Billion USD 97.809%
Intelligent Bio Solutions Inc. 5.59 Million USD -1609.5%
iSpecimen Inc. 6.07 Million USD -1473.825%
Standard BioTools Inc. 159.86 Million USD 40.163%
MDxHealth SA 121.92 Million USD 21.543%
23andMe Holding Co. 206.64 Million USD 53.709%
Medpace Holdings, Inc. 1.09 Billion USD 91.287%
Myriad Genetics, Inc. 312.9 Million USD 69.429%
Mainz Biomed B.V. 12.15 Million USD -686.674%
ENDRA Life Sciences Inc. 1.09 Million USD -8634.638%
NeoGenomics, Inc. 739.69 Million USD 87.068%
Neogen Corporation 1.44 Billion USD 93.357%
Inotiv, Inc. 588.04 Million USD 83.733%
Natera, Inc. 691.79 Million USD 86.173%
OpGen, Inc. 13.44 Million USD -611.537%
OPKO Health, Inc. 622.47 Million USD 84.633%
Psychemedics Corporation 6.59 Million USD -1349.803%
Prenetics Global Limited 44.01 Million USD -117.339%
Prenetics Global Limited 44.01 Million USD -117.339%
Precipio, Inc. 3.67 Million USD -2505.065%
RadNet, Inc. 2.07 Billion USD 95.386%
Sera Prognostics, Inc. 25.28 Million USD -278.349%
Sotera Health Company 2.68 Billion USD 96.44%
Neuronetics, Inc. 81.64 Million USD -17.169%
Star Equity Holdings, Inc. 21.67 Million USD -341.329%
Star Equity Holdings, Inc. 21.67 Million USD -341.329%
Trinity Biotech plc 83.38 Million USD -14.72%
T2 Biosystems, Inc. 62.83 Million USD -52.242%
Twist Bioscience Corporation 152.97 Million USD 37.467%
Exagen Inc. 34.25 Million USD -179.293%